autoimmune myositis

SHANGHAI, China / CAMBRIDGE, Massachusetts / AMSTERDAM, Netherlands — August 17, 2026 Zai Lab Limited and argenx announced positive...

Amsterdam, Netherlands, August 17, 2026 argenx SE announced positive topline results from the Phase 3 ALKIVIA study evaluating VYVGART...